株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の特殊酵素市場

Specialty Enzymes

発行 Global Industry Analysts, Inc. 商品コード 138694
出版日 ページ情報 英文 322 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.77円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
世界の特殊酵素市場 Specialty Enzymes
出版日: 2015年03月01日 ページ情報: 英文 322 Pages
概要

当レポートでは、世界の特殊酵素市場について調査分析し、製品セグメント別、地域 (米国、カナダ、日本、欧州、アジア太平洋地域、ラテンアメリカ) 別に、市場実績と予測、主要企業プロファイルなどを含めて、体系的な情報を提供しています。

第1章 イントロダクション、調査手法、製品の定義

第2章 エグゼクティブサマリー

  • 産業の概要
    • 特殊酵素
    • 見通し
  • 市場動向・課題・促進要因
    • 医薬品産業における治療への応用
    • 予防医療の重視で診断用酵素市場が成長
    • 人口老齢化で治療・診断用酵素の需要が増加
    • 堅実な研究活動が研究・バイオテクノロジー向け酵素の吉兆に
    • 生物触媒としての特殊酵素が大きな成長機会を提供
    • 酵素製法の進歩
    • 発展途上国が将来の市場成長を牽引
    • 欧州の食品酵素産業も特殊酵素へシフト
    • ヒトの健康における全身性酵素の重要性が増大
    • がん治療での酵素利用
    • 疼痛・炎症管理
    • 医療費の高騰
    • 酵素工学の進歩
    • 医療施設での利用が拡大
    • 酵素の固定化
    • 規制問題
    • 酵素治療の利点
  • 総合的な酵素市場:マクロの観点
    • 市場促進要因
    • 主な懸念事項
    • 主要企業
    • 競合シナリオ
  • 製品の概要
  • 製品の発表/イノベーション
  • 最近の産業活動
  • 世界の主要企業
    • Advanced Enzymes Technologies Limited (インド)
    • Advanced Vital Enzymes Ltd. (インド)
    • 天野エンザイム (日本)
    • AST Enzymes (米国)
    • Biocatalysts Ltd. (英国)
    • BBI Solutions (英国)
    • Chr. Hansen Holding AS (デンマーク)
    • Codexis, Inc. (米国)
    • Genzyme Corporation (米国)
    • Life Technologies Corporation (米国)
    • Meteoric Life Sciences (インド)
    • National Enzyme Company (米国)
    • ROCHE Holding, Inc. (米国)
    • Specialty Enzymes & Biotechnologies Co. (米国)
  • 世界市場の見通し

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • その他

第4章 競合情勢

  • 競合企業プロファイル:43社 (事業部/子会社を含めると48社)
    • 米国
    • カナダ
    • 日本
    • 欧州
    • アジア太平洋地域 (日本を除く)

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MCP-2056

This report analyzes the worldwide markets for Specialty Enzymes in US$ Million by the following Product Segments: Proteases, Polymerases, Carbohydrases, and Other Specialty Enzymes. The report is also analyzed by the following End-Use Applications: Pharmaceutical & Diagnostics, Research/ Biotechnology, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 41 companies including many key and niche players such as -

Advanced Enzymes Technologies Limited
Affymetrix, Inc.
Amano Enzyme, Inc.
Biocatalysts Ltd.
BBI Solutions

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Product Segments
      • Proteases
      • Polymerases
      • Carbohydrases
      • Other Specialty Enzymes
    • End-use Segments
      • Pharmaceutical & Diagnostics
      • Research/ Biotechnology
      • Other End-Uses

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Specialty Enzymes: Indispensable to the Pharmaceutical Industry
  • Outlook

2. MARKET TRENDS, ISSUES AND DRIVERS

  • Therapeutic Applications in the Pharmaceutical Industry: A Strong Growth Driver
    • Table 1: Global Market for Pharmaceuticals (2012): Percentage Share Breakdown of Value Sales by Medication Class (includes corresponding Graph/Chart)
  • Pharmaceutical Class and Respective Growth Drivers
  • Some Important Specialty Enzymes and their Therapeutic Areas
  • Sources of Therapeutic Enzymes
  • Factors Reducing the Potential of Therapeutic Enzymes
  • Specialty Enzymes Drive down Costs in Pharmaceutical Production
  • Focus on Preventive Medication Spurs Growth in the Diagnostic Enzymes Market
  • Aging Population Spurs Demand for Therapeutic and Diagnostic Enzymes
  • Demographic Statistics of Aging Populace: Unfurling the Market Potential
    • Table 2: Global Population Statistics for the 65+ Age Group: 2012 (includes corresponding Graph/Chart)
    • Table 3: Percentage of Population Aged 65 and Above in EU-27 Countries, the US and Japan (1960-2030) 2012 (includes corresponding Graph/Chart)
  • Role of Specialty Enzymes in Supporting Cardiovascular Health Boosts Market Prospects
    • Cardiovascular Disease (CVD) Facts and Figures
  • Robust Research Activity Bodes Well for Research and Biotechnology Enzymes
  • Specialty Enzyme as Biocatalysts in the Manufacture of Drugs and Fine Chemicals Offers Significant Growth Opportunities
  • Environment-Friendly Drug Manufacturing Processes Drive Demand for Specialty Enzymes
  • Advancements in Enzyme Manufacturing Processes Aids Growth
  • Enzyme Replacement Therapies for Lysosomal Storage Diseases (LSDs) Holds Promise
  • Developing Countries Drives Future Market Growth
    • Table 4: Global Value Market for Specialty Enzymes - Geographic Regions Ranked by CAGR for 2010-2018 - Asia-Pacific, Latin America, Rest of World, Japan, US, Canada and Europe (includes corresponding Graph/Chart)
  • Manufacturers in Developed Countries Move Production Base to Developing Markets
  • European Food Enzymes Industry Shifts Focus towards Specialty Enzymes from Commodity Enzymes
  • Growing Significance of Systemic Enzymes in Human Health Strengthens Market Prospects
  • Enzymes in Cancer Therapies Offers Immense Opportunities for Specialty Enzymes
  • Pain and Inflammation Management: Niche Application Area for Specialty Enzymes
  • Serratiopeptidase: An Agent of Inflammation Control and Pain Management
  • Spiraling Healthcare Costs Drives Demand for Supplemental Enzymes
  • Advancements in Enzyme Engineering Fuels Market Growth
  • Increasing Usage in Healthcare Facilities Bodes Well for the Market
  • Immobilization of Enzymes Opens up a World of Opportunities
  • Regulatory Issues to Ensure Safety of Enzyme Usage
  • Benefits of Enzyme Therapy

3. OVERALL (INDUSTRIAL AND SPECIALTY) ENZYMES MARKET: A MACRO PERSPECTIVE

  • Market Drivers
  • Major Concern
  • Major Players
  • Competitive Scenario
    • Table 5: Leading Players in the Global Enzymes Market (2012): Percentage Breakdown of Value Sales for Novozymes, Genencor, DSM, Tier 2 Companies and Others (includes corresponding Graph/Chart)
  • Industrial Enzymes Market Overview
  • Market Facts
  • Will Growth in Europe be Held Hostage By the Debt Crisis?
  • Optimistic Future
  • Technological Developments Set to Drive Growth for Industrial Enzymes
  • Competition in the Industrial Enzymes Market
    • Table 6: Leading Players in the Industrial Enzymes Market (2012): Percentage Share Breakdown of Value Sales for Novozymes, DSM, DuPont and Others (includes corresponding Graph/Chart)
  • Characteristics of the Industrial Enzymes Market

4. PRODUCT OVERVIEW

  • Enzymes: An Introduction
  • A Brief History
  • Categorization of Enzymes
  • Advantages of Enzymes over Chemical Catalysts
  • Classification of Enzymes Based on Application
  • Industrial Enzymes
  • Specialty Enzymes
    • Proteases
    • Polymerases
    • Carbohydrases
    • Other Specialty Enzymes
      • Nucleases
      • Lipases
      • Catalases
      • Oxidase
      • Laccases
      • Phytases

5. PRODUCT INTRODUCTIONS/INNOVATIONS

  • Enzymedica Unveils Digest Gold with ATProacents
  • Deerland Enzymes Unveils New Enzyme-based Technologies
  • Sekisui Enzymes Introduces New Thermostable Enzyme Range
  • Deerland Enzymes Introduces New ThioZymeYD Dietary Supplement
  • Sekisui Enzymes Introduces New β-Lactamase Enzyme
  • New England Biolabs Launches Two New DNA Polymerases
  • Cellectis Introduces Gene-specific TAL Nucleases
  • Eisai and Abbott Japan Introduce Lipacreon
  • Verenium Launches Xylathin
  • Novagen Introduces Novagen® KOD Xtreme™ Hot Start DNA Polymerase Kit

6. RECENT INDUSTRY ACTIVITY

  • Sekisui Diagnostics Announces New Headquarters in Massachusetts
  • Specialty Enzymes Expands Enzyme Products Manufacturing Capacity
  • Cornerstone Therapeutics Inks Agreement with Digestive Care
  • Codexis Extends Process and Catalyst Development Agreement with Merck
  • GENETRIX Inks Licensing Agreement with QIAGEN
  • Anil Bioplus to Establish Production Unit at Halol
  • Illumina Takes Over Epicentre Biotechnologies
  • DSM Inks Enzyme Supply Agreement with Codexis
  • Codexis Inks Biocatalysis Agreement With Dainippon Sumitomo Pharma
  • Teva Inks Licensing and Share Purchase Agreement with Cocrystal Discovery
  • Kilpest India, Biotools B&M Labs, and 2B Blackbio Launch 3B BlackBio Biotech India
  • Thermo Fisher Scientific Acquires Finnzymes

7. FOCUS ON SELECT GLOBAL PLAYERS

  • Advanced Enzymes Technologies Limited (India)
  • Advanced Vital Enzymes Ltd. (India)
  • Amano Enzyme, Inc. (Japan)
  • AST Enzymes (US)
  • Biocatalysts Ltd. (UK)
  • BBI Solutions (UK)
  • Chr. Hansen Holding AS (Denmark)
  • Codexis, Inc. (US)
  • Genzyme Corporation (US)
  • Life Technologies Corporation (US)
  • Meteoric Life Sciences (India)
  • National Enzyme Company (US)
  • ROCHE Holding, Inc. (US)
  • Specialty Enzymes & Biotechnologies Co. (US)

8. GLOBAL MARKET PERSPECTIVE

    • Table 7: World Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 8: World Historic Review for Specialty Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 9: World 15-Year Perspective for Specialty Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
  • Specialty Enzymes Market by Product Segment
    • Table 10: World Recent Past, Current & Future Analysis for Proteases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 11: World Historic Review for Proteases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 12: World 15-Year Perspective for Proteases by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 13: World Recent Past, Current & Future Analysis for Polymerases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 14: World Historic Review for Polymerases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 15: World 15-Year Perspective for Polymerases by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 16: World Recent Past, Current & Future Analysis for Carbohydrases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 17: World Historic Review for Carbohydrases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 18: World 15-Year Perspective for Carbohydrases by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 19: World Recent Past, Current & Future Analysis for Other Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 20: World Historic Review for Other Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 21: World 15-Year Perspective for Other Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
  • Specialty Enzymes Market by End-Use Segment
    • Table 22: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 23: World Historic Review for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 24: World 15-Year Perspective for Specialty Enzymes Consumption in Medical/ Diagnostics by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 25: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Research/Biotechnology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 26: World Historic Review for Specialty Enzymes Consumption in Research/ Biotechnology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 27: World 15-Year Perspective for Specialty Enzymes Consumption in Research/ Biotechnology by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 28: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 29: World Historic Review for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 30: World 15-Year Perspective for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current and Future Analysis
    • US Market for Specialty Enzymes - A Snapshot
    • Specialty and Industrial Enzymes - The Difference Blurring Out
    • Enzymes for Food Analysis and Testing - Challenges Faced
    • Aging Population Spurs Demand for Therapeutic and Diagnostic Enzymes
    • Table 31: Percentage of Population Aged 65 and Above in EU-27 Countries, the US and Japan (1960-2030) (includes corresponding Graph/Chart)
    • Product Launches
    • Recent Industry Activity
    • Key Players
  • B. Market Analytics
    • Table 32: US Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 33: US Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 34: US 15-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 35: US Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 36: US Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 37: US 15-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 38: Canadian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 39: Canadian Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 40: Canadian 15-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 41: Canadian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 42: Canadian Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 43: Canadian 15-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current and Future Analysis
    • Product Launch
    • Recent Industry Activity
    • Amano Enzyme, Inc. - A Japanese Key Player
  • B. Market Analytics
    • Table 44: Japanese Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 45: Japanese Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 46: Japanese 15-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 47: Japanese Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 48: Japanese Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 49: Japanese 15-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current and Future Analysis
    • Accelerating Trend towards Environmentally Friendly Enzymes
    • Enzymes for Research and Biotechnology to Report Faster Gains
    • European Food Enzymes Industry Shifts Focus towards Specialty Enzymes from Commodity Enzymes
  • B. Market Analytics
    • Table 50: European Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 51: European Historic Review for Specialty Enzymes by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 52: European 15-Year Perspective for Specialty Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 53: European Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 54: European Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 55: European 15-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 56: European Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 57: European Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 58: European 15-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current and Future Analysis
    • Product Launch
  • B. Market Analytics
    • Table 59: French Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 60: French Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 61: French 15-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 62: French Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 63: French Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 64: French 15-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 65: German Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 66: German Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 67: German 15-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 68: German Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 69: German Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 70: German 15-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 71: Italian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 72: Italian Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 73: Italian 15-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 74: Italian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 75: Italian Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 76: Italian 15-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current and Future Analysis
    • Key Players
  • B. Market Analytics
    • Table 77: UK Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 78: UK Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 79: UK 15-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 80: UK Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 81: UK Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 82: UK 15-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Current and Future Analysis
    • Recent Industry Activity
  • B. Market Analytics
    • Table 83: Spanish Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 84: Spanish Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 85: Spanish 15-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 86: Spanish Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 87: Spanish Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 88: Spanish 15-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

4f. RUSSIA

  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 89: Russian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 90: Russian Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 91: Russian 15-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 92: Russian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 93: Russian Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 94: Russian 15-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Current and Future Analysis
    • Recent Industry Activity
    • Chr. Hansen Holding AS (Denmark) - A Key Player
  • B. Market Analytics
    • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 96: Rest of Europe Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 97: Rest of Europe 15-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 98: Rest of Europe Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 99: Rest of Europe Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 100: Rest of Europe 15-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current and Future Analysis
    • Specialty Enzymes at Par with Industrial Enzymes in APAC
    • Asian Countries Drives Future Market Growth
    • Table 101: Global Value Market for Specialty Enzymes - Geographic Regions Ranked by CAGR for 2010-2018 - Asia-Pacific, Latin America, Rest of World, Japan, US, Canada and Europe (includes corresponding Graph/Chart)
    • Manufacturers in Developed Countries Move Production Base to Developing Markets
  • B. Market Analytics
    • Table 102: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region - China, India, South Korea and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 103: Asia-Pacific Historic Review for Specialty Enzymes by Geographic Region - China, India, South Korea and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 104: Asia-Pacific 15-Year Perspective for Specialty Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for China, India, South Korea and Rest of Asia-Pacific Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 105: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 106: Asia-Pacific Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 107: Asia-Pacific 15-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 108: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 109: Asia-Pacific Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 110: Asia-Pacific 15-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • Current and Future Analysis
    • Chinese Enzyme Demand by End-Use
    • Table 111: Chinese Enzyme Market (2012): Percentage Breakdown of Dollar Demand by End-Use Market - Industrial (Food & Beverage, Cleaning Products, Animal Feed, Ethanol Production, and Other Industrial) and Specialty (includes corresponding Graph/Chart)
    • Enzyme Demand by Enzyme Type
    • Table 112: Chinese Enzyme Market (2012): Percentage Breakdown of Dollar Demand by Enzyme Type - Carbohydrases (Amylases and Other Carbohydrases), Proteases, Lipases, Polymerases & Nucleases, and Other Enzymes (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 113: Chinese Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 114: Chinese Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 115: Chinese 15-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 116: Chinese Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 117: Chinese Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 118: Chinese 15-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

5b. INDIA

  • A. Market Analysis
    • Current and Future Analysis
    • India - A Fast Growing Enzymes Market
    • Recent Industry Activity
    • Key Players
  • B. Market Analytics
    • Table 119: Indian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 120: Indian Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 121: Indian 15-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 122: Indian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 123: Indian Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 124: Indian 15-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

5c. SOUTH KOREA

  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 125: South Korean Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 126: South Korean Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 127: South Korean 15-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 128: South Korean Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 129: South Korean Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 130: South Korean 15-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

5d. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 132: Rest of Asia-Pacific Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 133: Rest of Asia-Pacific 15-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 135: Rest of Asia-Pacific Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 136: Rest of Asia-Pacific 15-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 137: Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 2009 (includes corresponding Graph/Chart)
    • Table 138: Latin American Historic Review for Specialty Enzymes by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 139: Latin American 15-Year Perspective for Specialty Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for Brazil and Rest of Latin American Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 140: Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 141: Latin American Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 142: Latin American 15-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 143: Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 144: Latin American Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 145: Latin American 15-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

6a. BRAZIL

  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 146: Brazilian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 147: Brazilian Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 148: Brazilian 15-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 149: Brazilian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 150: Brazilian Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 151: Brazilian 15-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

6b. REST OF LATIN AMERICA

  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 152: Rest of Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 153: Rest of Latin American Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 154: Rest of Latin American 15-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 155: Rest of Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 156: Rest of Latin American Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 157: Rest of Latin American 15-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Current and Future Analysis
    • Recent Industry Activity
  • B. Market Analytics
    • Table 158: Rest of the World Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 159: Rest of the World Historic Review for Specialty Enzymes by Product Segment - Proteases, Polymerases, Carbohydrases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 160: Rest of the World 15-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Proteases, Polymerases, Carbohydrases and Other Enzymes Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 161: Rest of the World Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 162: Rest of the World Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 163: Rest of the World 15-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top